A significant development in the field of cancer immunotherapy is the discovery ofproteins like programmed cell death protein 1 (PD1), programmed cell death ligand 1 (PDL–1), and cytotoxic T lymphocyte-associated antigen 4 (CTLA4). Here, CTLA4 is linked to cancer.